Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited


Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP (including the 150mg and 300mg strengths). While Mylan has not received any reports of adverse eve (US Food Recalls) More More

Similar stories

Updates on NMDA Contaminations in Medications - Pharmacy Times

Updates on NMDA Contaminations in Medications  Pharmacy Times

Posted on 16 January 2020 | 3:00 am | Google News

FDA, companies add 3 heartburn meds to recall amid cancer concerns - KIRO Seattle

FDA, companies add 3 heartburn meds to recall amid cancer concerns  KIRO Seattle

Posted on 11 January 2020 | 3:00 am | Google News

RECALL: Mylan Pharmaceuticals says trace elements of NDMA found in some antacids - FOX 59 Indianapolis

RECALL: Mylan Pharmaceuticals says trace elements of NDMA found in some antacids  FOX 59 Indianapolis

Posted on 10 January 2020 | 3:00 am | Google News

Apellis Pharmaceuticals Phase 3 Success, And Other News: The Good, Bad, And Ugly Of Biopharma - Seeking Alpha

Apellis Pharmaceuticals Phase 3 Success, And Other News: The Good, Bad, And Ugly Of Biopharma  Seeking Alpha

Posted on 10 January 2020 | 3:00 am | Google News

Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited - FDA.gov

Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited  FDA.gov

Posted on 8 January 2020 | 3:00 am | Google News

Copyright © 2020 LastMinuteStuff.com | Contact info